1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
China Health Industries Holdings, Inc.

China Health Industries Holdings, Inc.

CHHE
China Health Industries Holdings, Inc.US flagOther OTC
0.00
USD
- -
- -
6,554.00Market Cap
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
TTM
Revenue per Share
1.01
0.95
0.14
0.16
0.16
0.12
0.1
0.1
0.14
0.15
0.1
- -
- -
- -
Basic EPS, GAAP
0.28
0.23
-0.02
-0.01
- -
- -
0.02
- -
0.05
0.05
0.02
-0.01
-0.01
-0.02
Free Cash Flow per Basic Share
0.15
0.33
0.01
-0.02
0.03
0.03
0.01
0.04
0.08
0.04
0.08
0.03
-0.64
-0.65
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.54
0.77
0.54
0.53
0.52
0.5
0.52
0.52
0.57
0.62
0.64
0.64
0.63
0.62
Tangible Book Value per Share
0.58
0.82
0.49
0.49
0.5
0.46
0.47
0.49
0.52
0.57
0.65
0.63
0.58
-0.05
Basic Weighted Avg Shares
62
62
62
62
63
66
66
66
66
66
66
66
66
66
Sales/Revenue/Turnover
63
59
9
10
10
8
6
7
9
10
6
- -
- -
- -
Operating Margin (%)
37.27
32.2
-14.99
-7.42
2.22
-3.6
-2.63
-7.12
49.18
49.26
28.71
-617,199.63
-1,651.39
-1,439.71
Depreciation Expense
- -
- -
- -
1
1
1
1
1
1
1
1
1
1
- -
Net Income, GAAP
18
14
-1
-1
- -
- -
1
- -
3
4
1
- -
- -
-1
Effective Tax Rate (%)
25.11
24.94
- -
- -
98.94
68.11
49.95
- -
29.5
29.23
36.13
- -
- -
- -
Profit Margin (%)
28.15
24.56
-13.86
-6.78
0.03
2.04
20.59
-4.83
35.65
35.75
19.89
-132,565.54
-366.35
-1,419.55
Working Capital
32
46
26
26
26
26
27
27
30
33
39
38
35
-6
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
37
52
37
36
36
34
35
35
37
40
45
43
39
-2
Return on Invested Capital (%)
56.76
30.58
- -
- -
0.01
-0.23
-0.21
- -
7.42
7.53
2.37
- -
- -
- -
Return on Capital (%)
70.88
35.14
- -
- -
0.01
0.52
3.64
- -
7.83
7.7
2.63
- -
- -
- -
Return on Common Equity (%)
71.55
35.52
-3.06
-1.99
0.01
0.49
3.91
-0.93
9.3
9.11
3.12
-0.85
-0.99
-3.31

Capital Structure

FRC

•

in mil. unless spec.
Sep'24
Dec'24
Mar'24
ST Debt
5
6
6
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
66
66
66
Market Capitalization
197
32
26

Working Capital

FRC

•

in mil. unless spec.
Sep'24
Dec'24
Mar'24
Total Current Assets
41
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
6
7
7
Payables & Accruals
1
1
1
ST Debt
5
6
6
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.71%
2.4%
-8.63%
Free Cash Flow
-266.12%
-401.59%
-2,098.01%
Net Income, GAAP
527.03%
-262.4%
15.49%
Sales/Revenue/Turnover
4,157.79%
8,320.77%
41,689.89%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
-0.01
- -
- -
-0.01
2023
-0.01
0.01
- -
- -
-0.01
2024
- -
-0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Sun Xin
Full Time Employees
32
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
3199-1 Longxiang Road Harbin People's Republic of China 150028
IPO Date
Mar 11, 2009
CIK
0001309057
Website
chinahealthindustries.com
Similar Companies
Hansoh Pharmaceutical Group Company Limited (3692.HK)
Agra Ventures Ltd. (AGRA.CN)
Cipher Pharmaceuticals Inc. (CPH.TO)
Changjiang Pharmaceutical Group Co., Ltd. (300391.SZ)
Dynavax Technologies Corporation (DVAX)
Yooma Wellness Inc. (LVVEF)
Business
China Health Industries Holdings, Inc. engages in the manufacturing, marketing, and distribution of health products, including medicines, health supplements, health devices, and cosmetics. Its core product portfolio consists of hemp derivative products, a range of medical drugs including tinctures, ointments, suppositories, liniments, and topical solutions, as well as health supplements and related wellness products. The company operates through subsidiaries such as Humankind and HLJ Huimeijia and offers a comprehensive variety of over 21 NMPA-approved medicines and 14 NMPA-approved health products. The firm’s distribution network spans extensively across China covering multiple provinces and key cities with a significant presence in the domestic pharmaceutical and health product market. Founded in 1989 and headquartered in Harbin, China, China Health Industries Holdings has diversified into several business segments including medical equipment and consumables distribution; hospital operation and management services; business factoring services; and distribution and marketing of pharmaceutical products. The company has also been developing digital infrastructure to expand e-commerce and B2C sales channels as part of its modernization and distribution strategy. Recent strategic developments include operational expansions in its hospital management business, benefiting from relaxed interest rate environments which enhance its financial leasing operations. The company is also leveraging the expansion and utilization of both organic and acquired hospitals to drive revenue growth, with 64 medical institutions and approximately 16,000 hospital beds as of mid-2023. These initiatives are part of its broader strategic push to integrate medical services with its pharmaceutical product offerings, signaling a shift towards a more comprehensive healthcare provider model. China Health Industries continues to focus on increasing product availability through both traditional sales agents and digital sales platforms across its primary market in China. Overall, China Health Industries Holdings operates primarily in the healthcare and pharmaceutical industry, targeting the Chinese domestic market with a broad portfolio of health-related products, hospital services, and medical equipment, supported by expanding financial leasing and hospital management businesses that reinforce its integrated healthcare services approach. The company remains listed on the OTC market under the ticker CHHE.